CANbridge Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,304	1,308	57	420	1,040	3,767
Market Cap Growth	2092.47%	2215.73%	-86.56%	-59.57%	-72.40%	-
Enterprise Value	1,248	1,345	169	278	515	6,284
Last Close Price	2.19	2.56	0.13	0.99	2.45	8.88
PE Ratio	65.60	79.35	-	-	-	-
PS Ratio	23.44	23.52	0.62	3.71	11.64	98.48
PB Ratio	-3.43	-3.44	-0.11	-9.59	2.98	4.43
P/TBV Ratio	-	-	-	-	3.54	4.78
EV/Sales Ratio	22.43	24.18	1.86	2.45	5.76	164.28
Debt / Equity Ratio	-0.05	-0.05	-0.29	-3.57	0.50	0.08
Net Debt / Equity Ratio	0.15	0.15	-0.26	-0.11	-1.00	-1.00
Net Debt / EBITDA Ratio	0.64	0.64	-0.38	-0.01	0.69	1.07
Net Debt / FCF Ratio	-	-	-1.02	-0.02	1.04	1.17
Asset Turnover	0.35	0.35	0.33	0.19	0.10	0.04
Inventory Turnover	0.94	0.94	3.69	4.16	2.59	1.77
Quick Ratio	0.18	0.18	0.08	0.54	1.73	4.17
Current Ratio	0.24	0.24	0.09	0.64	1.82	4.37
Return on Equity (ROE)	-	-	-	-281.91%	-96.51%	-
Return on Assets (ROA)	-41.06%	-41.06%	-83.10%	-41.75%	-35.90%	-55.38%
Return on Capital Employed (ROCE)	32.00%	32.00%	93.10%	-543.70%	-108.00%	-92.70%
Earnings Yield	1.26%	1.26%	-833.62%	-99.30%	-52.58%	-35.10%
FCF Yield	-	-	-230.71%	-74.27%	-32.21%	-19.30%
Buyback Yield / Dilution	-7.55%	-7.55%	-0.11%	-0.04%	-350.13%	-37.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.